Clinical Trials Logo

Clinical Trial Summary

This study aimed to explorie the biological basis of phlegm-dampness syndrome in patients with ischemic stroke using proteomics research techniques of urine and saliva.


Clinical Trial Description

Stroke is the disease with the highest mortality and disability in China, and the annual incidence of ischemic stroke is the highest. Atherosclerosis is the main cause of ischemic stroke. According to the theory of traditional Chinese medicine, the disease is closely related to the physical constitution of the individual. The main body constitution of the population in Lingnan area is phlegm dampness syndrome;Previous large cross-sectional studies have found that 65.3% of patients with ischemic stroke in Lingnan area have phlegm dampness syndrome. However, there is currently no biological evidence related to phlegm-dampness syndrome and ischemic stroke.In recent years, proteomics research technology has developed vigorously. The research samples have developed from blood obtained from minimally invasive to urine and saliva obtained non-invasively. Studies have found that urine proteins associated with AS include type I, type III collagen, 8-isoprostaglandin F2α, and saliva proteins include IL-1β, IL-6, TNF-α, and PGE2.Therefore, this research is dedicated to exploring the biological basis of phlegm-dampness syndrome in patients with ischemic stroke using proteomics research techniques of urine and saliva. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04472754
Study type Observational [Patient Registry]
Source Guangzhou University of Traditional Chinese Medicine
Contact
Status Not yet recruiting
Phase
Start date August 1, 2020
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT04545398 - Acute Meat and Alternative Intake (PRotEin DIet SatisfacTION Trial 3) N/A
Not yet recruiting NCT05622877 - The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque Phase 1
Completed NCT04064268 - Anabolic Potential of 3-hydroxybutyrate (3-OHB) and Whey Protein in a Human Catabolic Inflammatory Disease Model N/A
Recruiting NCT04804618 - Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT05376618 - Pilot Study on Proteomics of Erythrocyte Proteins in Patients With COPD Based on TMT Technology